Anti-AMPA receptor (IgG + IgA)

Elevated levels of Anti-AMPA receptor (IgG + IgA) antibodies suggest the presence of an autoimmune response targeting the AMPA receptors, which are critical components in the brain involved in fast synaptic transmission and cognitive functions such as learning and memory.

The presence of these antibodies is often associated with autoimmune encephalitis, a condition where the immune system mistakenly attacks healthy brain cells leading to inflammation.

Symptoms of this condition can vary but often include memory issues, seizures, psychiatric disturbances like hallucinations or agitation, and sometimes problems with movement or balance.

The diagnosis of autoimmune encephalitis typically involves not only blood tests like the Neural Zoomer Plus to identify specific antibodies but also may include imaging studies like MRI and possibly a lumbar puncture to examine cerebrospinal fluid.

Causes of autoimmune encephalitis can include underlying tumors that trigger an immune response (paraneoplastic syndromes), but many cases occur without a clear underlying cause.

AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) is a compound that is a specific agonist for the AMPA receptor, where it mimics the effects of the neurotransmitter glutamate. In some epilepsies, antibodies to AMPA receptors leads to neuron damage. The same is true for ischemia, where oxygen deprivation leads to excitotoxicity. Conversely, Alzheimer's disease is characterized by decreased AMPA activation and synapse loss.